Implants for prelingual or postlingual deafness, open angle glaucoma, and cardiovascular diseases
Conditions
Interventions
Group 1: In this study the following surveys will be conducted in 2020, 2021 and 2022:
1) seven group discussions (10-12 people each) in the three different areas (cochlear, glaucoma and cardiovascula
Sponsors
Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health (ceres), University of Cologne
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Glaucoma implants Group 1: Drug therapy only (drops); adults (= 50 years) with open angle glaucoma; time of diagnosis and start of drug therapy at least 12 months ago; at least 6 months postoperatively after implantation; visual acuity in the better eye = 30% Group 2: Micro-Stent ± drug therapy (drops); adults (= 50 years) with open angle glaucoma; time of diagnosis and start of drug therapy at least 12 months ago; visual acuity in the better eye = 30% Written declaration of consent by the patient German language skills that allow participation in the study cochlea implants Group 1: Postlingual deafness and implantation; middle age Group 2a: Prelingual deafness and childhood implantation Group 2b: Parents of participants from group 2a Minimum wearing period of the cochlea implant of 12 months after implantation Minimum age of 18 years Written declaration of consent by the patient German language skills that allow participation in the study Cardiovascular implants At least 6 months postoperatively after implant insertion Minimum age of 18 years Written declaration of consent by the patient German language skills that allow participation in the study
Exclusion criteria
Exclusion criteria: Cognitive or physical limitations that do not allow participation in the study For glaucoma implants age < 50 years
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Educational guidelines and best-practice models for doctor-patient communication and for cross-sectoral and inter-professional health care practice. Foundations for preference-sensitive decision-making in the context of implant technologies. | — |
Primary
| Measure | Time frame |
|---|---|
| Transmitting ethical, psychosocial, cultural and health literacy relevant aspects into the development and provision of implants. Increasing the patient orientation in implant development and provision. Promotion of the quality of life of people with implants. Reduction of the costs of care. | — |
Countries
Germany
Contacts
Public ContactLaura Harzheim
CERES Cologne Center for Ethics, Rights, Economics, and Sociel Sciences of Health, Universität zu Köln
Outcome results
None listed